Drug Shortage Report for GALANTAMINE ER

Last updated on 2021-02-10 History
Report ID 114761
Drug Identification Number 02443015
Brand name GALANTAMINE ER
Common or Proper name GALANTAMINE
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) GALANTAMINE
Strength(s) 8MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-06-01
Actual start date 2020-06-03
Estimated end date 2020-12-30
Actual end date 2021-02-09
Shortage status Resolved
Updated date 2021-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-02-10 English Compare
v14 2021-02-09 French Compare
v13 2021-02-09 English Compare
v12 2020-12-03 French Compare
v11 2020-12-03 English Compare
v10 2020-10-20 French Compare
v9 2020-10-20 English Compare
v8 2020-07-08 French Compare
v7 2020-07-08 English Compare
v6 2020-06-04 English Compare
v5 2020-06-03 French Compare
v4 2020-06-03 English Compare
v3 2020-06-02 English Compare
v2 2020-05-11 French Compare
v1 2020-05-11 English Compare

Showing 1 to 15 of 15